PROMOMED is the most prominent pharmaceutical company according to SCAN-Interfax

Corporate

02.02.2026

The biopharmaceutical company PROMOMED headed the media rating of pharmaceutical companies compiled by SCAN-Interfax and the telegram channel "Without a prescription" by the end of 2025[1]. The rating participants are ranked by quality and number of mentions in the media. PROMOMED company not only became the first in the industry, but also improved its own last year's result, demonstrating an increase of 87%.

Leadership in media rating serves as confirmation that the Company's news stories find wide response in the media and become key in the pharmaceutical industry.

PROMOMED also entered the top three in terms of the number of mentions. In the 12 months of 2025, the SCAN system, which includes 82,000 media outlets, recorded 9,234 articles mentioning the Company, which is 52% more than a year earlier. Media coverage in the reporting period also showed a 35% increase: almost 80 million people saw the Company's news.

The media activity of PROMOMED in 2025 was influenced by such significant events as the launch of the first domestic tirzepatide Tirzetta® and the first Russian semaglutide in tablets Semaltara®, as well as news about the entry into the pharmaceutical market of Iraq and Uzbekistan.

"Leadership in the visibility index, which takes into account not only the frequency, but also the credibility of sources, as well as the tone of publications, testifies to the high-quality level of the Company's communications. The results of the rating reflect the sustained attention of business and industry media to our strategic initiatives. The demand in the pharmaceutical industry is determined precisely by innovative and technological solutions. They make it possible to create drugs to combat diseases that until recently were considered untreatable. We are actively working in this direction and will continue our development," said Ekaterina Popova, Director of Corporate Communications at PROMOMED Group.

Sources